Literature DB >> 1204256

L-tetramisole. Enhancement of human lymphocyte response to antigen.

H F Pabst, J Crawford.   

Abstract

The anthelminthic drug L-Tetramisole enhanced in vitro lymphocyte transformation of normal young adults in the presence of PPD, Candida or measles antigen. This enhancement occurred regardless of evident pre-existing immunity to the antigen used. The increase in stimulation obtained by the drug and antigen combined, beyond that by antigen alone, varied between 1-25 and 5-99 for all three antigens in fourteen cell donors. Lymphocyte transformation was induced in seven individuals by the drug alone and suppressed in two. In levamisole dose--response tests, the optimum dose for this in vitro effect in six donors was similar for the three antigens.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1204256      PMCID: PMC1538306     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  10 in total

1.  Letter: Levamisole for recurrent herpes labialis.

Authors:  A Kint; L Verlinden
Journal:  N Engl J Med       Date:  1974-08-08       Impact factor: 91.245

2.  Letter: Treatment of aphthous stomatitis.

Authors:  H Verhaegen; J De Cree; J Brugmans
Journal:  Lancet       Date:  1973-10-13       Impact factor: 79.321

3.  The biochemical mechanism of action of the antinematodal drug tetramisole.

Authors:  H Van den Bossche; P A Janssen
Journal:  Biochem Pharmacol       Date:  1969-01       Impact factor: 5.858

4.  Levamisole inhibits and cures a solid malignant tumour and its pulmonary metastases in mice.

Authors:  G Renoux; M Renoux
Journal:  Nat New Biol       Date:  1972-12-13

5.  Effect of levamisole (NSC-177023) on in vitro human lymphocyte transformation.

Authors:  D Copeland; T Stewart; J Harris
Journal:  Cancer Chemother Rep       Date:  1974 Mar-Apr

6.  Drug-induced restoration of cutaneous delayed hypersensitivity in anergic patients with cancer.

Authors:  D Tripodi; L C Parks; J Brugmans
Journal:  N Engl J Med       Date:  1973-08-16       Impact factor: 91.245

7.  Levamisole and cell-mediated immunity.

Authors:  W H Churchill; J R David
Journal:  N Engl J Med       Date:  1973-08-16       Impact factor: 91.245

8.  Influence of tetramisole and its optical isomers on the mononuclear phagocytic system. Effect on carbon clearance in mice.

Authors:  J Hoebeke; G Franchi
Journal:  J Reticuloendothel Soc       Date:  1973-09

9.  Augmentation of chemotherapeutically induced remission of a murine leukemia by a chemical immunoadjuvant.

Authors:  M A Chirigos; J W Pearson; J Pryor
Journal:  Cancer Res       Date:  1973-11       Impact factor: 12.701

10.  Restoration of host defense mechanisms in man by levamisole.

Authors:  J Brugmans; V Schuermans; W De Cock; D Thienpont; P Janssen; H Verhaegen; L Van Nimmen; A C Louwagie; E Stevens
Journal:  Life Sci       Date:  1973-12-01       Impact factor: 5.037

  10 in total
  10 in total

1.  The effect of Levamisole on peripheral blood lymphocyte subpopulations in patients with rheumatoid arthritis and ankylosing spondylitis.

Authors:  M Rosenthal; U Trabert; W Müller
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

2.  Augmentation of the in vitro mitogenic response of owl monkey peripheral blood lymphocytes by levamisole and loss of this effect with the development of herpesvirus saimiri-induced lymphoma.

Authors:  R H Neubauer; H Rabin
Journal:  Clin Exp Immunol       Date:  1978-07       Impact factor: 4.330

Review 3.  Immunodeficiency in children.

Authors:  C B Wood
Journal:  Proc R Soc Med       Date:  1977-12

4.  The immunomodulatory effect of levamisole is influenced by postoperative changes and type of lymphocyte stimulant.

Authors:  E E Abdalla; I J Adam; G E Blair; A Boylston; H M Sue-Ling; P Finan; D Johnston
Journal:  Cancer Immunol Immunother       Date:  1995-09       Impact factor: 6.968

5.  Abnormal adherent cell function in aplastic anaemia demonstrated using levamisole in cultures for T lymphocyte colony-forming cells (TL-CFC).

Authors:  M Y Gordon; J A King; E C Gordon-Smith
Journal:  Clin Exp Immunol       Date:  1981-04       Impact factor: 4.330

6.  Restoration by levamisole of immune responses suppressed in tumor-bearing mice.

Authors:  M Shiraishi; K Himeno; K Nomoto
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

7.  In vivo effect of levamisole on cellular and humoral immunity in normal chickens.

Authors:  E Soppi; O Lassila; M K Viljanen; O P Lehtonen; J Eskola
Journal:  Clin Exp Immunol       Date:  1979-12       Impact factor: 4.330

8.  Inhibition of the E-rosette formation of T-lymphocytes by aggregated human IgG and restoration by levamisole.

Authors:  W De Cock; J De Cree; H Verhaegen
Journal:  Immunology       Date:  1978-08       Impact factor: 7.397

9.  In vitro reversal of cellular unresponsiveness induced by levamisole.

Authors:  H Golding; B Golding; R Jacobson; R Lomnitzer; H J Koornhof; A R Rabson
Journal:  Clin Exp Immunol       Date:  1976-11       Impact factor: 4.330

10.  Effects of levamisole on normal and abnormal leukocyte locomotion.

Authors:  D G Wright; C H Kirkpatrick; J I Gallin
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.